Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaap Verweij

Showing results (31-40 of 234) with videos related to

Pageof 24
Sort By:
Current Opinion in Oncology|September 1, 2007
Gynaecological sarcomasStefan Sleijfer, Caroline Seynaeve, Jaap Verweij
European Journal of Cancer (Oxford, England : 1990)|December 11, 2008
Cancer clinical trial outcomes: any progress in tumour-size assessment?Jaap Verweij, Patrick Therasse, Elizabeth Eisenhauer, et al.
Nature Reviews. Clinical Oncology|September 30, 2009
Chemotherapy: Adjuvant chemotherapy in older patients with breast cancerAgnes Jager, Jaap Verweij, Stefan Sleijfer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
The future of drug development? Seeking evidence of activity of novel drugs in small groups of patientsStefan Sleijfer, Karla Ballman, Jaap Verweij
The Oncologist|November 30, 2005
Using single-agent therapy in adult patients with advanced soft tissue sarcoma can still be considered standard careStefan Sleijfer, Caroline Seynaeve, Jaap Verweij
Nature Clinical Practice. Oncology|February 1, 2008
Drug Insight: gastrointestinal stromal tumors (GIST)--the solid tumor model for cancer-specific treatmentStefan Sleijfer, Erik Wiemer, Jaap Verweij
Advances in Experimental Medicine and Biology|July 3, 2008
GIST as the model of paradigm shift towards targeted therapy of solid tumors: update and perspective on trial designJaap Verweij, Caroline Seynaeve, Stefan Sleijfer
The Oncologist|June 1, 2010
(Pre-)clinical pharmacology and activity of pazopanib, a novel multikinase angiogenesis inhibitorPaul Hamberg, Jaap Verweij, Stefan Sleijfer
Clinical Pharmacokinetics|March 3, 2006
Clinical pharmacokinetics of docetaxel : recent developmentsSharyn D Baker, Alex Sparreboom, Jaap Verweij
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Paclitaxel repackaged in an albumin-stabilized nanoparticle: handy or just a dandy?Alex Sparreboom, Sharyn D Baker, Jaap Verweij
Pageof 24

Showing results (31-40 of 234) with videos related to

Sort By:
Pageof 24
Current Opinion in Oncology|September 1, 2007
Gynaecological sarcomasStefan Sleijfer, Caroline Seynaeve, Jaap Verweij
European Journal of Cancer (Oxford, England : 1990)|December 11, 2008
Cancer clinical trial outcomes: any progress in tumour-size assessment?Jaap Verweij, Patrick Therasse, Elizabeth Eisenhauer, et al.
Nature Reviews. Clinical Oncology|September 30, 2009
Chemotherapy: Adjuvant chemotherapy in older patients with breast cancerAgnes Jager, Jaap Verweij, Stefan Sleijfer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
The future of drug development? Seeking evidence of activity of novel drugs in small groups of patientsStefan Sleijfer, Karla Ballman, Jaap Verweij
The Oncologist|November 30, 2005
Using single-agent therapy in adult patients with advanced soft tissue sarcoma can still be considered standard careStefan Sleijfer, Caroline Seynaeve, Jaap Verweij
Nature Clinical Practice. Oncology|February 1, 2008
Drug Insight: gastrointestinal stromal tumors (GIST)--the solid tumor model for cancer-specific treatmentStefan Sleijfer, Erik Wiemer, Jaap Verweij
Advances in Experimental Medicine and Biology|July 3, 2008
GIST as the model of paradigm shift towards targeted therapy of solid tumors: update and perspective on trial designJaap Verweij, Caroline Seynaeve, Stefan Sleijfer
The Oncologist|June 1, 2010
(Pre-)clinical pharmacology and activity of pazopanib, a novel multikinase angiogenesis inhibitorPaul Hamberg, Jaap Verweij, Stefan Sleijfer
Clinical Pharmacokinetics|March 3, 2006
Clinical pharmacokinetics of docetaxel : recent developmentsSharyn D Baker, Alex Sparreboom, Jaap Verweij
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Paclitaxel repackaged in an albumin-stabilized nanoparticle: handy or just a dandy?Alex Sparreboom, Sharyn D Baker, Jaap Verweij
Pageof 24